Impact of flavonols on cardiometabolic biomarkers:  A meta-analysis of randomized controlled human  trials to explore the role of inter-individual variability - Université Clermont Auvergne Accéder directement au contenu
Article Dans Une Revue (Article De Synthèse) Nutrients Année : 2017

Impact of flavonols on cardiometabolic biomarkers:  A meta-analysis of randomized controlled human  trials to explore the role of inter-individual variability

Dragan Milenkovic
Tatjana Ruskovska
Emilie Combet
  • Fonction : Auteur

Résumé

Several epidemiological studies have linked flavonols with decreased risk of cardiovascular disease (CVD). However, some heterogeneity in the individual physiological responses to the consumption of these compounds has been identified. This meta‐analysis aimed to study the effect of flavonol supplementation on biomarkers of CVD risk such as, blood lipids, blood pressure and plasma glucose, as well as factors affecting their inter‐individual variability. Data from 18 human randomized controlled trials were pooled and the effect was estimated using fixed or random effects meta‐analysis model and reported as difference in means (DM). Variability in the response of blood lipids to supplementation with flavonols was assessed by stratifying various population subgroups: age, sex, country, and health status. Results showed significant reductions in total cholesterol (DM = −0.10 mmol/L; 95% CI: −0.20, −0.01), LDL cholesterol (DM = −0.14 mmol/L; Nutrients 2017, 9, 117 2 of 21 95% CI: −0.21, 0.07), and triacylglycerol (DM = −0.10 mmol/L; 95% CI: −0.18, 0.03), and a significant increase in HDL cholesterol (DM = 0.05 mmol/L; 95% CI: 0.02, 0.07). A significant reduction was also observed in fasting plasma glucose (DM = −0.18 mmol/L; 95%CI: −0.29, −0.08), and in blood pressure (SBP: DM = −4.84 mmHg; 95% CI: −5.64, −4.04; DBP: DM = −3.32 mmHg; 95% CI: -4.09, -2.55). Subgroup analysis showed a more pronounced effect of flavonol intake in participants from Asian countries and in participants with diagnosed disease or dyslipidemia, compared to healthy and normal baseline values. In conclusion, flavonol consumption improved biomarkers of CVD risk, however, country of origin and health status may influence the effect of flavonol intake on blood lipid levels
Fichier principal
Vignette du fichier
2017_Menezes_Impact_Nutrients_{F6ED9D0B-B70A-4351-8518-D0ABB1AA537C}.pdf (1.61 Mo) Télécharger le fichier
Origine : Accord explicite pour ce dépôt
Loading...

Dates et versions

hal-01506654 , version 1 (12-04-2017)

Licence

Copyright (Tous droits réservés)

Identifiants

Citer

Regina Menezes, Ana Rodriguez-Mateos, Antonia Kaltsatou, Antonio González-Sarrías, Arno Greyling, et al.. Impact of flavonols on cardiometabolic biomarkers:  A meta-analysis of randomized controlled human  trials to explore the role of inter-individual variability. Nutrients, 2017, 9 (2), ⟨10.3390/nu9020117⟩. ⟨hal-01506654⟩
877 Consultations
74 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More